Crossmark

Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance

Crossref DOI link: https://doi.org/10.1186/s40246-018-0183-1

Published Online: 2018-11-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Langerud, Jonas

Jarhelle, Elisabeth

Van Ghelue, Marijke

Ariansen, Sarah Louise

Iversen, Nina
License Information

Text and Data Mining valid from 2018-11-20
More Information

Article History

Received: 31 August 2018

Accepted: 8 November 2018

First Online: 20 November 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.